pyrvinium has been researched along with Candidiasis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| May, RC; Simm, C | 1 |
| Bax, M; Cammue, BP; Cools, TL; Cos, P; De Brucker, K; De Cremer, K; Lanckacker, E; Thevissen, K | 1 |
2 other study(ies) available for pyrvinium and Candidiasis
| Article | Year |
|---|---|
Zinc and Iron Homeostasis: Target-Based Drug Screening as New Route for Antifungal Drug Development.
Topics: A549 Cells; Antifungal Agents; Artemisinins; Candida albicans; Candidiasis; Drug Development; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Homeostasis; Humans; Iron; Macrophages; Metals; Microbial Sensitivity Tests; Mycoses; Phagocytosis; Pyrvinium Compounds; Small Molecule Libraries; Zinc | 2019 |
Artemisinins, new miconazole potentiators resulting in increased activity against Candida albicans biofilms.
Topics: Amphotericin B; Antifungal Agents; Artemisinins; Artesunate; Biofilms; Candida albicans; Candidiasis; Caspofungin; Drug Synergism; Echinocandins; Fluconazole; Hexachlorophene; Lipopeptides; Miconazole; Microbial Sensitivity Tests; Pyrvinium Compounds; Reactive Oxygen Species | 2015 |